NCT04110717View on ClinicalTrials.gov

Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Reducing Excess Body Weight

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

October 9, 2020

Primary Completion Date

March 23, 2021

Study Completion Date

March 23, 2021

Conditions
OverweightObesityOverweight and ObesityOverweight or ObesityMetabolic Syndrome
Interventions
DEVICE

Vestal Device

Vestibular nerve stimulator

DEVICE

Control Device

Control Device

BEHAVIORAL

Hypocaloric Diet

Hypocaloric diet

Trial Locations (1)

D04 T6F4

St. Vincent's University Hospital, Dublin

Sponsors

Lead Sponsor

Neurovalens Ltd.

Collaborators (1)

Exploristics Ltd
All Listed Sponsors
collaborator

University College Dublin

OTHER

collaborator

Exploristics Ltd

UNKNOWN

collaborator

Compliance Solutions Ltd.

INDUSTRY

lead

Neurovalens Ltd.

INDUSTRY

NCT04110717 - Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control as a Means of Reducing Excess Body Weight | Biotech Hunter | Biotech Hunter